ITRMF · Iterum Therapeutics plc · Proposed Sales
$0.03
+0.01 (+34.78%)
At close · Jul 21
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“This condition raises substantial doubt about the Company's ability to continue as a going concern for one year from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$446
Shares
44.66M
Volume · Jul 21
18.8K
Avg daily vol (3M)
99.9K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.